Mathes Company’s Amgen AMGN Stock Holding History

Mathes Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Hold	3,095	–	–	0.35%	56
2026 Q1	$1.09M	Sell	3,095 -10	-0.3%	-$3.56K	0.4%	51
2025 Q4	$1.02M	Hold	3,105	–	–	0.36%	55
2025 Q3	$876K	Sell	3,105 -60	-2%	-$17.4K	0.31%	55
2025 Q2	$884K	Hold	3,165	–	–	0.33%	58
2025 Q1	$986K	Hold	3,165	–	–	0.4%	56
2024 Q4	$825K	Sell	3,165 -40	-1%	-$11.9K	0.3%	63
2024 Q3	$1.03M	Sell	3,205 -125	-4%	-$40.9K	0.36%	62
2024 Q2	$1.04M	Sell	3,330 -300	-8%	-$88.1K	0.38%	60
2024 Q1	$1.03M	Sell	3,630 -50	-1%	-$14.6K	0.39%	61
2023 Q4	$1.06M	Hold	3,680	–	–	0.44%	58
2023 Q3	$989K	Sell	3,680 -23	-0.6%	-$5.74K	0.46%	58
2023 Q2	$822K	Buy	+3,703	New	+$859K	0.36%	63
2022 Q4	$970K	Sell	3,693 -250	-6%	-$67K	0.49%	57
2022 Q3	$889K	Sell	3,943 -12	-0.3%	-$2.91K	0.5%	55
2022 Q2	$962K	Sell	3,955 -215	-5%	-$52.7K	0.47%	61
2022 Q1	$1.01M	Hold	4,170	–	–	0.39%	67
2021 Q4	$938K	Sell	4,170 -15	-0.4%	-$3.17K	0.32%	74
2021 Q3	$890K	Sell	4,185 -50	-1%	-$11.5K	0.33%	74
2021 Q2	$1.03M	Sell	4,235 -200	-5%	-$49.2K	0.37%	67
2021 Q1	$1.1M	Sell	4,435 -47	-1%	-$11.2K	0.43%	60
2020 Q4	$1.03M	Sell	4,482 -23	-0.5%	-$5.3K	0.42%	62
2020 Q3	$1.15M	Hold	4,505	–	–	0.53%	52
2020 Q2	$1.06M	Hold	4,505	–	–	0.53%	53
2020 Q1	$913K	Sell	4,505 -65	-1%	-$14.2K	0.61%	46
2019 Q4	$1.1M	Hold	4,570	–	–	0.51%	54
2019 Q3	$884K	Hold	4,570	–	–	0.46%	62
2019 Q2	$842K	Hold	4,570	–	–	0.45%	64
2019 Q1	$868K	Sell	4,570 -935	-17%	-$179K	0.44%	64
2018 Q4	$1.07M	Hold	5,505	–	–	0.68%	50
2018 Q3	$1.14M	Hold	5,505	–	–	0.53%	56
2018 Q2	$1.02M	Hold	5,505	–	–	0.48%	60
2018 Q1	$938K	Sell	5,505 -25	-0.5%	-$4.59K	0.44%	61
2017 Q4	$962K	Hold	5,530	–	–	0.44%	60
2017 Q3	$1.03M	Sell	5,530 -1,460	-21%	-$259K	0.49%	60
2017 Q2	$1.2M	Sell	6,990 -1,175	-14%	-$191K	0.58%	47
2017 Q1	$1.34M	Sell	8,165 -25	-0.3%	-$4.15K	0.71%	44
2016 Q4	$1.2M	Sell	8,190 -2,775	-25%	-$418K	0.66%	46
2016 Q3	$1.83M	Sell	10,965 -2,655	-19%	-$449K	1.04%	33
2016 Q2	$2.07M	Sell	13,620 -25	-0.2%	-$3.89K	1.21%	29
2016 Q1	$2.04M	Sell	13,645 -1,100	-7%	-$163K	1.23%	30
2015 Q4	$2.39M	Sell	14,745 -100	-0.7%	-$15.7K	1.36%	25
2015 Q3	$2.05M	Sell	14,845 -1,350	-8%	-$213K	1.35%	23
2015 Q2	$2.49M	Hold	16,195	–	–	1.33%	22
2015 Q1	$2.59M	Buy	16,195 +975	+6%	+$154K	1.33%	19
2014 Q4	$2.42M	Sell	15,220 -575	-4%	-$89.6K	1.27%	25
2014 Q3	$2.22M	Buy	15,795 +1,825	+13%	+$238K	1.12%	29
2014 Q2	$1.65M	Buy	13,970 +3,520	+34%	+$407K	0.82%	44
2014 Q1	$1.29M	Hold	10,450	–	–	0.69%	48
2013 Q4	$1.19M	Buy	+10,450	New	+$1.19M	0.64%	48

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Mathes Company's AMGN Position: Q2 2026 in Review

Mathes Company held its Amgen (AMGN) position steady in Q2 2026 at 3,095 shares worth $1.12M. The position accounts for 0.35% of the portfolio, ranked #56.

Mathes Company first reported a position in AMGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.59M in Q1 2015. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Mathes Company held 3,095 shares of Amgen worth $1.12M as of Q2 2026.
Mathes Company left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.35% of Mathes Company's portfolio in Q2 2026, its #56 holding.
Mathes Company first reported a position in Amgen in Q4 2013 and has held it in 50 quarters since.
Mathes Company's Amgen position peaked at $2.59M in Q1 2015.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mathes Company's 13F filing for Q2 2026, filed 11 Aug 2026.